HeartSciences COO and Board Member Mark Hilz passes away at 67

HeartSciences Inc.

Mark Hilz, COO, Corporate Secretary and Board member, died April 1, 2026 after an illness.
He served on the Board since 2013 and as COO/Secretary since March 2022.
Company will not hire a new COO; no changes expected to business or FDA clearance plans.
MyoVista wavECG 510(k) submission remains on track (submitted Dec 2025).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.